MedTrace Logo

Study of Cabazitaxel in Patients With Metastatic Breast Cancer Previously Treated With Taxanes

NCT01693549 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2017-08-01

No results posted yet for this study

Summary

The purpose of this study is to determine whether cabazitaxel is effective in the treatment of metastatic breast cancer.

Conditions

Interventions

DRUG

Cabazitaxel

Sponsors & Collaborators

  • Sanofi

    collaborator INDUSTRY

  • Hellenic Cooperative Oncology Group

    lead OTHER

Principal Investigators

  • Angelos Koutras, MD · Division of Oncology,Dept of Internal Medicine,University Hospital of Patras

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2017-07-10
Completion
2017-07-20

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01693549 on ClinicalTrials.gov